Previous 10 | Next 10 |
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the commencement of a proposed underwritten public offering of 4,000,000 shares of its common...
Outset Medical is performing in line with my expectations which I outlined at the time of the public offering. I look forward to the contribution from the home market in 2021, expected to have a huge impact on the top line. I remain constructive on the shares and look forward to i...
Guam to receive HHS emergency deployment of Outset Medical’s mobile, easy-to-use dialysis technology for patients with kidney failure. Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to...
Gainers: Alterity Therapeutics (ATHE) +120%, Outset Medical (OM) +17%, Keros Therapeutics (KROS) +9%, Inovio Pharmaceuticals (INO) +10%, Fulgent Genetics (FLGT) +14%.Losers: RAPT Therapeutics (RAPT) -46%, IMAC Holdings (IMAC) -10%, BioNTech (B...
Outset Medical (OM): Q3 Non-GAAP EPS of -$2.31 misses by $0.49; GAAP EPS of -$3.44 misses by $0.88.Revenue of $13.76M (+423.2% Y/Y) beats by $2.23M.Shares -4.59%.Press Release For further details see: Outset Medical EPS misses by $0.49, beats on revenue
Strong Quarter Driven by Accelerating Acute Market Penetration and Significant Margin Expansion Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming virtual investo...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2020 after the close of t...
Bank of America launches coverage on Outset Medical (OM) with a Buy rating on what it sees as major tailwinds for the company."Outset is trying to both disrupt the in hospital/acute care dialysis market and shift dialysis into the home - two opportunities that together represent roughly $10bn...
Five biotechs, two medical device makers, a solar panel mounting manufacturer, and a Chinese retailer are scheduled to raise $2.0 billion in the week ahead. Several companies could join the IPO calendar early in the week, including McAfee and Datto Holding. Street research is expe...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...